Animal Vaccines Market Size, Share, Trends, Growth Outlook

Animal Vaccines Market is estimated to increase at a growth rate of 6.4% CAGR over the forecast period from 2024 to 2030.

The Animal Vaccines Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Attenuated Live Vaccines, Inactivated Vaccines, Subunit Vaccines, DNA Vaccines, Recombinant Vaccines), By Animal Type (Livestock, Poultry, Aqua, Ruminants, Swine, Companion, Canine, Feline, Others), By Route of Administration (Subcutaneous, Intramuscular, Intranasal).

An Introduction to Animal Vaccines Market in 2024

The Animal Vaccines Market in 2024 is experiencing robust growth, driven by the increasing prevalence of infectious diseases, growing awareness of preventive healthcare measures, and advancements in vaccine technology to protect animals from a wide range of pathogens. Animal vaccines play a critical role in promoting animal health, welfare, and productivity by preventing diseases, reducing transmission, and minimizing economic losses in livestock production, aquaculture, and companion animal sectors. With advancements in antigen design, adjuvant formulations, and vaccine delivery systems, the market offers a diverse portfolio of vaccines, including inactivated, live attenuated, subunit, and recombinant vaccines, targeting viral, bacterial, and parasitic pathogens across different animal species. Moreover, the integration of vaccination programs, biosecurity measures, and One Health approaches further enhances disease prevention, antimicrobial stewardship, and sustainable agriculture practices, driving market expansion and supporting global efforts to address emerging infectious threats and zoonotic diseases.

Animal Vaccines Market Trend: Increasing Focus on Preventive Healthcare and Disease Control in Animal Husbandry

A prominent trend in the Animal Vaccines market is the growing emphasis on preventive healthcare and disease control measures in animal husbandry. With the rise in global demand for animal protein products, there is a heightened awareness among livestock producers about the importance of vaccination in maintaining herd health and productivity. This trend is driving the adoption of vaccines for various infectious diseases in livestock and companion animals, as proactive vaccination strategies are recognized as effective means to prevent disease outbreaks, reduce treatment costs, and ensure food safety and security.

Animal Vaccines Market Driver: Rising Incidence of Zoonotic Diseases and Disease Outbreaks

A key driver propelling the Animal Vaccines market is the escalating incidence of zoonotic diseases and disease outbreaks affecting both animals and humans. The increasing interconnectivity between animal and human populations, coupled with factors such as globalization, urbanization, and climate change, has led to the emergence and spread of infectious diseases with significant public health implications. Vaccination plays a crucial role in controlling zoonotic diseases, preventing transmission between animals and humans, and mitigating the economic and health impacts of outbreaks. The need to combat zoonotic diseases and ensure animal and public health safety drives the demand for innovative and effective animal vaccines.

Animal Vaccines Market Opportunity: Expansion of Companion Animal Vaccination Services and Product Portfolio

An opportunity in the Animal Vaccines market lies in the expansion of companion animal vaccination services and product portfolio. With the growing pet humanization trend and increasing pet ownership rates worldwide, there is a rising demand for comprehensive veterinary care, including vaccination services, for companion animals such as dogs, cats, and horses. Veterinary clinics and pet healthcare providers can capitalize on this opportunity by offering a wide range of vaccines tailored to the specific needs of companion animals, including core vaccines for common infectious diseases and lifestyle vaccines for pets with unique exposure risks. Additionally, there is potential for the development of novel vaccine formulations, such as oral or intranasal vaccines, to enhance convenience and compliance in companion animal vaccination programs.

Animal Vaccines Market Segmentation

By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Animal Vaccines Market Companies

Boehringer Ingelheim Gmbh
Ceva Santé Animale
Dechra Pharmaceuticals Plc
Elanco
Heska
Idexx Laboratories Inc
Merck & Co. Inc
Norbrook Inc
Vetoquinol S.A.
Virbac
Zoetis

 

 

Reasons to Buy the Animal Vaccines Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Animal Vaccines Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Animal Vaccines Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Animal Vaccines Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Animal Vaccines Market Size Outlook, $ Million, 2021 to 2030
3.2 Animal Vaccines Market Outlook by Type, $ Million, 2021 to 2030
3.3 Animal Vaccines Market Outlook by Product, $ Million, 2021 to 2030
3.4 Animal Vaccines Market Outlook by Application, $ Million, 2021 to 2030
3.5 Animal Vaccines Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Animal Vaccines Market Industry
4.2 Key Market Trends in Animal Vaccines Market Industry
4.3 Potential Opportunities in Animal Vaccines Market Industry
4.4 Key Challenges in Animal Vaccines Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Animal Vaccines Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Animal Vaccines Market Outlook By Segments
7.1 Animal Vaccines Market Outlook by Segments
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

8 North America Animal Vaccines Market Analysis And Outlook To 2030
8.1 Introduction to North America Animal Vaccines Markets in 2024
8.2 North America Animal Vaccines Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Animal Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

9 Europe Animal Vaccines Market Analysis And Outlook To 2030
9.1 Introduction to Europe Animal Vaccines Markets in 2024
9.2 Europe Animal Vaccines Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Animal Vaccines Market Size Outlook By Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

10 Asia Pacific Animal Vaccines Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Animal Vaccines Markets in 2024
10.2 Asia Pacific Animal Vaccines Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Animal Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

11 South America Animal Vaccines Market Analysis And Outlook To 2030
11.1 Introduction to South America Animal Vaccines Markets in 2024
11.2 South America Animal Vaccines Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Animal Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

12 Middle East And Africa Animal Vaccines Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Animal Vaccines Markets in 2024
12.2 Middle East and Africa Animal Vaccines Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Animal Vaccines Market size Outlook by Segments, 2021-2030
By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Boehringer Ingelheim Gmbh
Ceva Santé Animale
Dechra Pharmaceuticals Plc
Elanco
Heska
Idexx Laboratories Inc
Merck & Co. Inc
Norbrook Inc
Vetoquinol S.A.
Virbac
Zoetis

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Animal Type
Livestock
Poultry
Aqua
Ruminants
Swine
Companion
Canine
Feline
Others
By Route of Administration
Subcutaneous
Intramuscular
Intranasal